AbbVie Inc.
DE ˙ XTRA ˙ US00287Y1091
185,70 € ↓ -2,40 (-1,28%)
2026-06-02
AKTIENPREIS
SecurityDE:4AB / AbbVie Inc.
InstitutionCypress Capital, LLC
Latest Disclosed Ownership14,858 shares
Latest Disclosed Value $ 3,231,466
Cypress Capital, LLC reports 1.31% decrease in ownership of 4AB / AbbVie Inc.

On April 28, 2026 - Cypress Capital, LLC filed a 13F-HR form disclosing ownership of 14,858 shares of AbbVie Inc. (DE:4AB) valued at $2,754,673 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 15,055 shares of AbbVie Inc.. This represents a change in shares of -1.31% during the quarter. The current value of the position is $2,759,131 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-28 2026-03-31 13F ABBVIE COM 00287Y109 14,858 -197 -1.31 3,231 -6.05 0.9194
2026-02-06 2025-12-31 13F ABBVIE COM 00287Y109 15,055 192 1.29 3,440 -0.06 0.9631
2025-10-23 2025-09-30 13F ABBVIE COM 00287Y109 14,863 -462 -3.01 3,441 20.99 0.9845
2025-08-07 2025-06-30 13F ABBVIE COM 00287Y109 15,325 -209 -1.35 2,845 -12.60 0.8262
2025-04-25 2025-03-31 13F ABBVIE COM 00287Y109 15,534 292 1.92 3,255 20.16 0.9382
2025-02-03 2024-12-31 13F ABBVIE COM 00287Y109 15,242 -156 -1.01 2,709 -10.92 0.7746
2024-11-12 2024-09-30 13F ABBVIE COM 00287Y109 15,398 14,491 1,597.68 3,041 1,861.29 0.7844
2024-10-29 2024-06-30 13F/A-2 ABBVIE COM 00287Y109 907 -20,264 -95.72 156 -95.98 0.4892
2024-10-28 2024-06-30 13F/A-1 ABBVIE COM 00287Y109 907 -20,025 156 0.4892
2024-08-22 2024-06-30 13F ABBVIE COM 00287Y109 14,769 -6,163 2,533 0.7565
2024-10-29 2024-03-31 13F ABBVIE COM 00287Y109 21,171 20,439 2,792.21 3,855 3,311.50 1.0543
2024-12-02 2023-12-31 13F/A-1 ABBVIE COM 00287Y109 732 45 6.55 113 10.78 0.5129
2024-02-05 2023-12-31 13F ABBVIE COM 00287Y109 20,932 169 3,244 0.9848
2024-12-02 2023-09-30 13F/A-1 ABBVIE COM 00287Y109 687 0 0.00 102 10.87 0.6783
2023-11-09 2023-09-30 13F ABBVIE COM 00287Y109 20,763 -680 3,095 0.9496
2024-12-02 2023-06-30 13F/A-1 ABBVIE COM 00287Y109 687 59 9.39 93 -8.00 0.5947
2023-08-07 2023-06-30 13F ABBVIE COM 00287Y109 21,443 412 2,889 0.8696
2024-12-10 2023-03-31 13F/A-1 ABBVIE COM 00287Y109 628 0 0.00 100 -0.99 0.6503
2023-04-27 2023-03-31 13F ABBVIE COM 00287Y109 21,031 -2,621 3,352 1.1012
2024-12-26 2022-12-31 13F/A-1 ABBVIE COM 00287Y109 628 0 0.00 101 20.24 0.6291
2023-02-01 2022-12-31 13F ABBVIE COM 00287Y109 23,652 75 3,822 1.2622
2024-12-26 2022-09-30 13F/A-1 ABBVIE COM 00287Y109 628 0 0.00 84 -12.50 0.4846
2023-02-01 2022-09-30 13F ABBVIE COM 00287Y109 23,577 534 3,164,269 1.1876
2024-12-26 2022-06-30 13F/A-1 ABBVIE COM 00287Y109 628 0 0.00 96 -4.95 0.6669
2022-08-04 2022-06-30 13F ABBVIE COM 00287Y109 23,043 -3,327 3,529 0.5132
2024-12-26 2022-03-31 13F/A-1 ABBVIE COM 00287Y109 628 -877 -58.27 102 -50.25 0.5318
2022-05-09 2022-03-31 13F ABBVIE COM 00287Y109 26,370 1,060 4,275 0.5366
2024-12-26 2021-12-31 13F/A-1 ABBVIE COM 00287Y109 1,505 -25,031 -94.33 204 -92.91 0.6867
2022-02-10 2021-12-31 13F ABBVIE COM 00287Y109 25,310 -1,226 3,427 0.4043
2022-02-10 2021-09-30 13F ABBVIE COM 00287Y109 26,536 510 1.96 2,862 -2.39 0.3635
2021-08-16 2021-06-30 13F Abbvie COM 00287Y109 26,026 1,895 7.85 2,932 12.29 2.8649
2021-05-17 2021-03-31 13F Abbvie COM 00287Y109 24,131 879 3.78 2,611 4.82 1.0651
2021-02-16 2020-12-31 13F ABBVIE COM 00287Y109 23,252 -351 -1.49 2,491 22.59 1.1290
2020-11-12 2020-09-30 13F ABBVIE COM 00287Y109 23,603 -2,587 -9.88 2,032 -20.96 0.9428
2020-08-20 2020-06-30 13F ABBVIE COM 00287Y109 26,190 26,190 2,571 1.1380
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.